Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Heba Abdelazeem"'
Autor:
Heba Abdelazeem, Ly Tu, Raphaël Thuillet, Mina Ottaviani, Achraf Boulfrad, Thomas Beck, Amira Senbel, Salma Mani, Yves Castier, Alice Guyard, Alexy Tran-Dinh, Jamel El-Benna, Dan Longrois, Adam M. Silverstein, Christophe Guignabert, Xavier Norel
Publikováno v:
European Journal of Pharmacology. 946:175579
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1348c7477c66d009d5eddf929397aa7
https://doi.org/10.1016/j.ejphar.2023.175579
https://doi.org/10.1016/j.ejphar.2023.175579
Autor:
Heba Abdelazeem, Ly Tu, Raphaël Thuillet, Mina Ottaviani, Achraf Boulfrad, Amira Senbel, Salma Mani, Yves Castier, Alice Guyard, Alexy Tran-Dinh, Jamel El-Benna, Dan Longrois, Adam M. Silverstein, Christophe Guignabert, Xavier Norel
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41c18749f4118975371797e963846717
https://doi.org/10.2139/ssrn.4105281
https://doi.org/10.2139/ssrn.4105281
Autor:
Gulsev, Ozen, Khadija, Aljesri, Heba, Abdelazeem, Xavier, Norel, Gulsum, Turkyılmaz, Saygın, Turkyılmaz, Gokce, Topal
Publikováno v:
Life sciences. 286
Thromboxane (TxAUsing isolated organ bath, saphenous vein and internal mammary artery preparations were incubated with TP receptor antagonist, TxS inhibitor, aspirin, IP or EP4 receptor antagonist. Then prostaglandin (PG)ETP receptor antagonist inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c3a9e6e28fb2bc0d04de2670c2526b71
https://pubmed.ncbi.nlm.nih.gov/34688694
https://pubmed.ncbi.nlm.nih.gov/34688694
Autor:
Yasmine, Amgoud, Amira, Senbel, Amel, Bouhadoun, Heba, Abdelazeem, Gulsev, Ozen, Ines, Savané, Hasanga D, Manikpurage, Salma, Mani, Alexy, Tran-Dinh, Yves, Castier, Alice, Guyard, Dan, Longrois, Adam M, Silverstein, Xavier, Norel
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids. 172
Prostacyclin (PGITo study the effect of 17β-estradiol (E2) on the PGIFollowing E2-treatments of isolated HPA and cultured hPASMC, we measured: 6-keto-Prostaglandin FIncubation with E2 (24/48 h, doses ≥ 10 nM) significantly increased the expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::38c07460c6afd0e15f14f177cca0b9da
https://pubmed.ncbi.nlm.nih.gov/34403986
https://pubmed.ncbi.nlm.nih.gov/34403986
Autor:
Xavier, Norel, Yukihiko, Sugimoto, Gulsev, Ozen, Heba, Abdelazeem, Yasmine, Amgoud, Amel, Bouhadoun, Wesam, Bassiouni, Marie, Goepp, Salma, Mani, Hasanga D, Manikpurage, Amira, Senbel, Dan, Longrois, Akos, Heinemann, Chengcan, Yao, Lucie H, Clapp
Publikováno v:
Pharmacological Reviews
Prostaglandins are derived from arachidonic acid metabolism through cyclooxygenase activities. Among prostaglandins (PGs), prostacyclin (PGI2) and PGE2 are strongly involved in the regulation of homeostasis and main physiologic functions. In addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8bbaf68b1f1ff003195ab9d849c868cc
https://pubmed.ncbi.nlm.nih.gov/32962984
https://pubmed.ncbi.nlm.nih.gov/32962984
Autor:
Gulsev, Ozen, Yasmine, Amgoud, Heba, Abdelazeem, Salma, Mani, Chabha, Benyahia, Amel, Bouhadoun, Alexy, Tran-Dinh, Yves, Castier, Alice, Guyard, Dan, Longrois, Adam M, Silverstein, Xavier, Norel
Publikováno v:
Prostaglandins, leukotrienes, and essential fatty acids. 160
Pulmonary hypertension (PH) is a progressive and life-threating lung disorder characterized by elevated pulmonary artery pressure and vascular remodeling. PH is classified into five groups, and one of the most common and lethal forms, PH Group-III is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4840bcda63a217aa073308fb4e3ae10b
https://pubmed.ncbi.nlm.nih.gov/32673988
https://pubmed.ncbi.nlm.nih.gov/32673988
Autor:
Gulsum Turkyilmaz, Saygin Turkyilmaz, Heba Abdelazeem, Gulsev Ozen, Xavier Norel, Gokce Topal, Khadija Aljesri
Publikováno v:
Life Sciences. 286:120073
Aims Thromboxane (TxA2) is synthesized from arachidonic acid (AA) via thromboxane synthase (TxS) enzyme and induces vasoconstriction via TP receptor. Our aim is to compare the effects of aspirin, TxS inhibitor and TP receptor antagonist on vascular r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::005a3ab30d9e7304db0c240183b16ef4
https://doi.org/10.1016/j.lfs.2021.120073
https://doi.org/10.1016/j.lfs.2021.120073
Autor:
Dan Longrois, Heba Abdelazeem, Salma Mani, Xavier Norel, Ines Savané, Yasmine Amgoud, Alexy Tran-Dinh, Gulsev Ozen, Yves Castier, Alice Guyard, Adam M. Silverstein, Amel Bouhadoun, Amira Senbel, Hasanga D. Manikpurage
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 172:102321
Introduction Prostacyclin (PGI2) is synthetized by PGI2 synthase (PGIS) and induces vasorelaxation via activation of cyclic AMP (cAMP) generating IP-receptor. Several components of the PGI2 signaling pathway are reduced in patients with pulmonary hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa44c0754d12e44b0011706f66d2ba85
https://doi.org/10.1016/j.plefa.2021.102321
https://doi.org/10.1016/j.plefa.2021.102321
Autor:
Gulsev, Ozen, Chabha, Benyahia, Yasmine, Amgoud, Jigisha, Patel, Heba, Abdelazeem, Amel, Bouhadoun, Sonia, Yung, Fangfang, Li, Youcef, Mahieddine, Adam M, Silverstein, Yves, Castier, Aurélie, Cazes, Dan, Longrois, Lucie H, Clapp, Xavier, Norel
Publikováno v:
Prostaglandinsother lipid mediators. 146
Pulmonary hypertension (PH) is characterized by an elevation of mean pulmonary artery pressure and it is classified into five groups. Among these groups, PH Group-III is defined as PH due to lung disease or hypoxia. Prostacyclin (PGI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1490b573a246d5fb303a462bbb222ae2
https://pubmed.ncbi.nlm.nih.gov/31672620
https://pubmed.ncbi.nlm.nih.gov/31672620
Autor:
Heba Abdelazeem, Adam M. Silverstein, Youcef Mahieddine, Amel Bouhadoun, Dan Longrois, Aurélie Cazes, Fangfang Li, Sonia Yung, Jigisha Patel, Yves Castier, Gulsev Ozen, Xavier Norel, Yasmine Amgoud, Lucie H. Clapp, Chabha Benyahia
Publikováno v:
Prostaglandins and Other Lipid Mediators
Prostaglandins and Other Lipid Mediators, 2020, 146, pp.106388. ⟨10.1016/j.prostaglandins.2019.106388⟩
Prostaglandins and Other Lipid Mediators, Elsevier, 2020, 146, pp.106388-. ⟨10.1016/j.prostaglandins.2019.106388⟩
Prostaglandins and Other Lipid Mediators, 2020, 146, pp.106388. ⟨10.1016/j.prostaglandins.2019.106388⟩
Prostaglandins and Other Lipid Mediators, Elsevier, 2020, 146, pp.106388-. ⟨10.1016/j.prostaglandins.2019.106388⟩
International audience; Pulmonary hypertension (PH) is characterized by an elevation of mean pulmonary artery pressure and it is classified into five groups. Among these groups, PH Group-III is defined as PH due to lung disease or hypoxia. Prostacycl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e624f8248bf9148f66a4a25d33c6e0b6
https://doi.org/10.1016/j.prostaglandins.2019.106388
https://doi.org/10.1016/j.prostaglandins.2019.106388